Theseus Pharmaceuticals CEO Timothy Clackson's 2022 pay falls 38% to $4.4M
Theseus Pharmaceuticals reports 2022 executive compensation
By ExecPay News
Published: April 26, 2023
Theseus Pharmaceuticals reported fiscal year 2022 executive compensation information on April 26, 2023.
In 2022, three executives at Theseus Pharmaceuticals received on average a compensation package of $2.7M, a 9% increase compared to previous year.
Average pay of disclosed executives at Theseus Pharmaceuticals
Timothy P. Clackson, Chief Executive Officer, received $4.4M in total, which decreased by 38% compared to 2021. 79% of Clackson's compensation, or $3.5M, was in option awards. Clackson also received $314K in non-equity incentive plan, $570K in salary, as well as $17K in other compensation.
William C. Shakespeare, Co-Founder, received a compensation package of $2M, which increased by 17% compared to previous year. 67% of the compensation package, or $1.4M, was in option awards.
David P. Kerstein, Chief Medical Officer, earned $1.8M in 2022, a 72% increase compared to previous year.
Related executives
You may also like
Source: SEC filing on April 26, 2023.